#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	13852	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2112	652.3	1	SNP	n	C1184T	0	.	.	1184	1184	C	1457	1457	C	815	C	743	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	13852	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2112	652.3	0	HET	.	.	.	C451T	.	451	451	C	724	724	C	803	C,T	407,329	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	24664	23S	2890	2890	99.9	23S.l6.c4.ctg.1	3589	685.5	0	.	n	.	0	T695C	SNP	695	695	T	1084	1084	C	827	C,T	747,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	24664	23S	2890	2890	99.9	23S.l6.c4.ctg.1	3589	685.5	0	.	n	.	0	A1638G	SNP	1638	1638	A	2027	2027	G	806	G,A	376,349	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	24664	23S	2890	2890	99.9	23S.l6.c4.ctg.1	3589	685.5	0	.	n	.	0	T1971C	SNP	1971	1971	T	2360	2360	C	770	C	688	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	24664	23S	2890	2890	99.9	23S.l6.c4.ctg.1	3589	685.5	1	SNP	n	A2045G	0	.	.	2045	2045	A	2434	2434	A	799	A	737	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	24664	23S	2890	2890	99.9	23S.l6.c4.ctg.1	3589	685.5	1	SNP	n	C2597T	0	.	.	2597	2597	C	2986	2986	C	750	C,T	685,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_O_01412c	folP.WHO_O_01412c	1	1	27	1666	folP	855	855	100.0	folP.l6.c30.ctg.1	1552	107.0	1	SNP	p	R229S	1	.	.	685	687	AGC	989	991	AGC	173;172;171	A;G;C	154;155;153	folP.WHO_O_01412c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4956	gyrA	2751	2751	99.85	gyrA.l6.c4.ctg.1	3465	142.6	1	SNP	p	S91F	1	.	.	271	273	TTC	630	632	TTC	146;148;149	T;T;C	138;140;140	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4956	gyrA	2751	2751	99.85	gyrA.l6.c4.ctg.1	3465	142.6	1	SNP	p	D95G	1	.	.	283	285	GGC	642	644	GGC	145;146;144	G;G,A;C	137;137,1;136	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4956	gyrA	2751	2751	99.85	gyrA.l6.c4.ctg.1	3465	142.6	1	SNP	p	G95N	0	.	.	283	285	GGC	642	644	GGC	145;146;144	G;G,A;C	137;137,1;136	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_O_01438	mtrR.WHO_O_01438	1	1	27	1324	mtrR	633	633	100.0	mtrR.l15.c30.ctg.1	1330	99.3	1	SNP	p	G45D	0	.	.	133	135	GGC	462	464	GGC	156;153;157	G;G;C,T	145;143;146,1	mtrR.WHO_O_01438:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	698	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	907	76.3	0	.	n	.	0	A197.	DEL	197	197	A	601	601	A	152	A	133	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5644	parC	2304	2304	100.0	parC.l6.c4.ctg.1	2921	192.7	1	SNP	p	D86N	0	.	.	256	258	GAC	595	597	GAC	211;210;211	G;A;C	186;183;192	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5644	parC	2304	2304	100.0	parC.l6.c4.ctg.1	2921	192.7	1	SNP	p	R87I	0	.	.	259	261	CGT	598	600	CGT	213;214;217	C;G;T	191;192;195	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5644	parC	2304	2304	100.0	parC.l6.c4.ctg.1	2921	192.7	1	SNP	p	S87R	1	.	.	259	261	CGT	598	600	CGT	213;214;217	C;G;T	191;192;195	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5644	parC	2304	2304	100.0	parC.l6.c4.ctg.1	2921	192.7	1	SNP	p	R87W	0	.	.	259	261	CGT	598	600	CGT	213;214;217	C;G;T	191;192;195	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5644	parC	2304	2304	100.0	parC.l6.c4.ctg.1	2921	192.7	1	SNP	p	S88P	0	.	.	262	264	TCC	601	603	TCC	217;218;218	T;C;C	193;199;198	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	3746	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2747	136.0	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1509	1511	GGC	175;175;175	G;G,T;C	156;153,1;156	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	3428	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2285	149.2	1	SNP	p	A311V	0	.	.	931	933	GCC	1167	1169	GCC	186;190;186	G;C;C	171;175;172	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3428	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2285	149.2	1	SNP	p	I312M	1	.	.	934	936	ATG	1170	1172	ATG	186;188;190	A;T;G	173;173;173	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3428	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2285	149.2	1	SNP	p	T316P	0	.	.	946	948	ACC	1182	1184	ACC	196;198;202	A;C;C	180;182;182	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3428	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2285	149.2	1	SNP	p	V316T	1	.	.	946	948	ACC	1182	1184	ACC	196;198;202	A;C;C	180;182;182	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3428	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2285	149.2	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1683	1685	ACC	179;181;182	A;C;C	155;161;165	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3428	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2285	149.2	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1737	1739	GCG	208;207;209	G;C;G	184;183;184	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3428	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2285	149.2	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1737	1739	GCG	208;207;209	G;C;G	184;183;184	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3428	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2285	149.2	1	SNP	p	G542S	0	.	.	1624	1626	GGT	1860	1862	GGT	170;169;169	G;G;T	150;149;147	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3428	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2285	149.2	1	SNP	p	G545S	1	.	.	1633	1635	AGC	1869	1871	AGC	162;162;162	A;G;C	141;138;140	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3428	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2285	149.2	1	SNP	p	P551S	0	.	.	1651	1653	CCG	1887	1889	CCG	149;150;150	C,G;C;G	118,4;119;118	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5464	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	2959	184.0	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1566	1568	CCG	190;190;189	C;C;G	168;175;168	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	1868	porA	1146	1146	99.91	porA.l15.c4.ctg.1	1856	100.1	0	.	p	.	0	M83fs	FSHIFT	247	247	A	636	636	C	122	C	111	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	2744	porB1b	1038	1038	100.0	porB1b.l15.c4.ctg.1	1647	165.8	1	SNP	p	G120K	1	.	.	358	360	AAG	731	733	AAG	227;229;231	A;A,C;G	214;215,1;213	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	2744	porB1b	1038	1038	100.0	porB1b.l15.c4.ctg.1	1647	165.8	1	SNP	p	N121D	0	.	.	361	363	AAC	734	736	AAC	231;234;235	A;A;C	215;219;214	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	2744	porB1b	1038	1038	100.0	porB1b.l15.c4.ctg.1	1647	165.8	1	SNP	p	A121N	1	.	.	361	363	AAC	734	736	AAC	231;234;235	A;A;C	215;219;214	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	10174	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	4876	208.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1058	rpsJ	312	312	100.0	rpsJ.l6.c30.ctg.1	1009	104.3	1	SNP	p	V57M	1	.	.	169	171	ATG	528	530	ATG	233;236;235	A;T;G	214;214;212	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
